Subject: RE: Drug cost estimation
From: Ben Kamarck <[email-masked]>
To: Tamar Gabunia <[email-masked]>, Graeme Robertson <[email-masked]>, Ekaterine Adamia <[email-masked]>
Date: Wed, 15 Jan 2020 13:48:57 +0000

Hi Tamar,

As you can imagine, the generic price will be a lot lower than the US commercial price.  Will this cause you any issues?  If the price is too low, will it make it seem like an inferior product?

Ben

From: Tamar Gabunia <[email-masked]>

Sent: Tuesday, January 14, 2020 7:57 PM

To: Ben Kamarck <[email-masked]>; Graeme Robertson <[email-masked]>; Ekaterine Adamia <[email-masked]>

Subject: [EXTERNAL] Drug cost estimation

Hi Ben

Since the hep C program will be switching to the new drugs to be imported we should have an estimated price established by the local state entity. This is also part of a customs clearance procedure.  I thought we may be able to share some
sources/references which would indicate the drug costs in some other countries?

Many thanks!

პატივისცემით,

თამარ გაბუნია

მინისტრის პირველი მოადგილე

Sincerely,

Tamar Gabunia,
MD, MPH

First Deputy Minister